Crowdfunding

We have a gift for your kindness!

Claim Gift
LIVE


Support Aditya

Help 2-Year-Old Aditya Fight Spinal Muscular Atrophy (SMA Type 2)

Help 2-Year-Old Aditya Fight Spinal Muscular Atrophy (SMA Type 2)

AM
Campaigner Details
Impactguru Verified

Archana Mondal
Kolkata West Bengal Contact
A
Beneficiary Details
Impactguru Verified

Aditya
Child of Archana Mondal
Patient Hospitalised at
Peerless Hospitex Hospital and Research Centre , Kolkata

of $ 983,607

3,990 Donors
Every social media share can bring $80
AM
Campaigner Details
Impactguru Verified

Archana Mondal
Kolkata West Bengal | Contact
A
Beneficiary Details
Impactguru Verified

Aditya
Child of Archana Mondal
Patient Hospitalised at
Peerless Hospitex Hospital and Research Centre , Kolkata

Latest Update


Dear Donors,

Aditya is currently at home and under regular doctor follow-up. Treatment with Risdiplam, along with ongoing physiotherapy and medication, continues as advised by the medical team.

Your continued prayers and generous support are deeply needed. Every donation helps ensure uninterrupted treatment and gives strength on Aditya’s path toward recovery.

Story


Hello Everyone,

My name is Archana Mondal, and I am begging for your help to save my precious son, Aditya. He is only 2 years and 7 months old, but he is fighting a cruel enemy — Spinal Muscular Atrophy (SMA Type 2), a rare genetic disease that slowly weakens his muscles, making even the simplest things like sitting, swallowing, and breathing a struggle.


Our only hope lies in a life-saving gene therapy called Zolgensma. The total treatment cost is around ₹16 crore, which is unimaginable for us. Thankfully, Novartis has made this miracle drug available at a reduced price of ₹9 crore, payable in installments. Even so, this amount is far beyond what we can afford.


We have exhausted all our savings, borrowed from family, and yet we are nowhere close to the amount needed. Every day that passes, Aditya’s condition worsens. His bright smile hides the pain and weakness growing inside him.


Please, I humbly ask you to help us save Aditya’s life. No contribution is too small — every rupee brings us closer to giving him a chance to run, play, and grow like other children. If you cannot donate, please share our plea so more hearts can join our fight.


From the depths of my heart, thank you for your kindness and prayers. You are our hope.

Archana Mondal

(Mother of Aditya)


------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------


সবাইকে শুভেচ্ছা,

আমার নাম অর্চনা মন্ডল, এবং আমি আমার প্রিয় ছেলে অদিতিকে বাঁচানোর জন্য আপনার সাহায্যের আবেদন করছি। ও মাত্র ২ বছর ৭ মাসের, কিন্তু সে এক কঠোর শত্রুর সঙ্গে লড়াই করছে — স্পাইনাল মাসকুলার অ্যাট্রোফি (SMA টাইপ ২), একটি বিরল জেনেটিক রোগ যা ধীরে ধীরে তার পেশী দুর্বল করে দিচ্ছে, এমনকি বসা, গিলতে এবং শ্বাস নিতে ও অসুবিধা হচ্ছে।

আমাদের একমাত্র আশা হলো জীবন রক্ষাকারী জিন থেরাপি জোলজেনস্মা। মোট চিকিৎসার খরচ প্রায় ₹১৬ কোটি, যা আমাদের পক্ষে অসম্ভব। সৌভাগ্যবশত, নোভার্টিস এই জীবনবাঁচানো ওষুধটি ₹৯ কোটি মূল্যে ইন্সটলমেন্টে প্রদান করছে। তবুও এই অর্থ আমাদের পক্ষে বহন করা অনেক কঠিন।

আমরা আমাদের সব সঞ্চয় শেষ করে ফেলেছি, আত্মীয়-স্বজন থেকে ধার নিয়েছি, তারপরেও চিকিৎসার জন্য দরকারি অর্থের কাছাকাছি পৌঁছাতে পারিনি। প্রতিদিন অদিতার অবস্থা খারাপ হচ্ছে। তার উজ্জ্বল হাসির আড়ালে রয়েছে অসহায়তার বেদনা।

অনুগ্রহ করে, আমি বিনীতভাবে আপনার সাহায্য চাই অদিতার জীবন বাঁচাতে। কোনো দানই ছোট নয় — প্রতিটি টাকা আমাদের ওকে দৌড়ানো, খেলা এবং অন্য শিশুর মতো বড় হওয়ার সুযোগের কাছে নিয়ে যায়। আপনি যদি দান করতে না পারেন, তাহলে আমাদের এই আবেদনটি শেয়ার করুন যাতে আরও বেশি মানুষ এই লড়াইয়ে আমাদের সঙ্গে দাঁড়ায়।

আমার অন্তরের গভীর থেকে, আপনাদের সদয়তা এবং প্রার্থনার জন্য ধন্যবাদ। আপনিরাই আমাদের আশা।

অর্চনা মন্ডল

(অদিতার মা)

The goal amount of the campaign may be higher than the attached estimates to address and aid the post-hospitalization expenses/contingencies including but not limited to prolonged medication, diagnostics, rehabilitation therapies, and follow-up doctor visits/consultations which vary from disease to disease.
NO INFLUENCE DECLARATION
Impact Guru does not influence / control the decision of the campaigner / patient with respect to choice of hospital / doctor / healthcare treatment or the cost / estimate of any such treatment. Such decision is in entirety of campaigner / patient / beneficiary and / or their family members without any interference and / or say of Impact Guru. Impact Guru is absolved of any liability in respect thereof.
LANGUAGE OF STORY/STATEMENT DECLARATION
The language, story, facts mentioned on this fundraising page is in entirety statements / opinions / thoughts shared by the campaigner / beneficiary or persons authorised on their behalf and shall not be construed as statement / thoughts / opinions of or on behalf of Impact Guru.
TREATMENT COST ESTIMATES
Impact Guru has no control over the cost estimates provided by hospitals / clinics / pharmaceutical companies etc. The cost estimates vary depending on the city and / or hospital where the patient is under treatment, professional fees of the treating doctors, drugs / medicines / therapies chosen for treatment by patient or patient’s family at their own discretion including but not limited to unique medical conditions / circumstances pertaining to each patient.
UTILIZATION OF FUNDS
In the rare scenario of surplus funds remaining within the fundraising campaign due to any of the following circumstances:
i) Completion of the Patient's treatment; ii) Receipt of requisite funding for the Patient from alternative sources; iii) Eligibility of the Patient for free treatment under any scheme or the receipt of free treatment by other means; iv) Demise of the Patient; v) Fulfilment of the fundraising campaign's objectives; vi) Termination of the fundraising campaign for any reason; vii) Reduction in the cost of the drug/therapy required for SMA treatment; viii) Prescription of an alternative therapy for the Patient's treatment
Impact Guru shall ensure that such surplus funds are allocated for the following purposes:
i) Provision of alternative drug therapy treatments as prescribed by the attending physician for the Patient/s (if applicable). Such utilization may span across multiple years, as SMA therapies/treatments typically entail long-term, recurring costs; ii) If surplus funds persist even after the aforementioned allocation, they shall be employed to assist other patients on Impact Guru in their life-saving treatment, with the objective of maximizing social impact; iii) donors of the fundraising campaign at the sole discretion of Impact Guru may be offered the option to claim a pro-rata refund of surplus funds.
PATIENT DEATH UPDATE
Upon the death of the patient, the Campaigner / close relative / POC on behalf of the patient shall be duty bound to inform Impact Guru immediately within two (2) hours of such occurrence and turn off the donations tab (through the internal access granted) on the campaign on Impact Guru Platform in order to stop fundraising on the campaign. In the event Campaigner or authorised/designated POC on behalf of the patient fails to do so and campaign continues raising funds due to such non-information/non action, the Campaigner or authorised/designated POC on behalf of the patient shall be personally liable any consequences thereof; further, Impact Guru shall be disclaimed of all the liabilities occurring with respect to such post death fundraising and the such liability in entirety shall accrue on Campaigner or authorised/designated POC on behalf of the patient. In the event of death of the patient, Impact Guru’s Patient Death Policy at Terms Of Use shall apply.
Documents

Updates(2)


#1 (03 Feb, 2026) - From Archana Mondal

Dear Donors,

Aditya is currently at home and under regular doctor follow-up. Treatment with Risdiplam, along with ongoing physiotherapy and medication, continues as advised by the medical team.

Your continued prayers and generous support are deeply needed. Every donation helps ensure uninterrupted treatment and gives strength on Aditya’s path toward recovery.

#2 (03 Oct, 2025) - From Archana Mondal

Dear Donors,

Baby Aditya, 2 years and 7 months old, is courageously battling Spinal Muscular Atrophy (SMA) Type 2, a rare genetic disorder that weakens his muscles and makes sitting, swallowing, and breathing difficult.

He has not yet received Risdiplam or any other treatment, and his condition continues to worsen. The only treatment that can save his life is Zolgensma, a one-time gene therapy costing ₹16 crore. Thanks to an EMI plan from Novartis, the upfront cost is ₹9 crore, offering a chance to give him a healthy childhood.

Your support, through donations or sharing his story, can help Aditya receive the treatment he urgently needs and live a life full of hope and joy.

Comment



Fundraisers for This Cause




Touch more lives with your Kindness !

playstore
X

Access and manage fundraisers at your fingertips!

Get important fundraising tips, a personalized dashboard and real-time updates with ImpactGuru’s new and improved crowdfunding app.

qrcode

Scan the QR code to download the app

mobile-out-image
mobile-inside-image